open access
A patient with undetected haemophilia C and recurrent bleedings during anticoagulant therapy
open access
Abstract
Haemophilia C is an uncommon bleeding disorder caused by XI factor deficiency. The bleeding
intensity depends mainly on patient’s genotype, other coagulation factors activity and platelets
activity, less on XI factor activity so it is possible that asymptomatic illness reveals after anticoagulant
is administered.
The article describes a case of a patient with haemophilia C detected while she was being
diagnosed due to recurrent bleedings during rivaroxaban and vitamin K antagonist therapy.
Abstract
Haemophilia C is an uncommon bleeding disorder caused by XI factor deficiency. The bleeding
intensity depends mainly on patient’s genotype, other coagulation factors activity and platelets
activity, less on XI factor activity so it is possible that asymptomatic illness reveals after anticoagulant
is administered.
The article describes a case of a patient with haemophilia C detected while she was being
diagnosed due to recurrent bleedings during rivaroxaban and vitamin K antagonist therapy.
Keywords
haemophilia C; acenocoumarol; XI factor; rivaroxaban; bleeding disorder
About this articleTitle
A patient with undetected haemophilia C and recurrent bleedings during anticoagulant therapy
Journal
Journal of Transfusion Medicine
Issue
Article type
Case report
Pages
101-105
Published online
2016-11-22
Bibliographic record
Journal of Transfusion Medicine 2016;9(3):101-105.
Keywords
haemophilia C
acenocoumarol
XI factor
rivaroxaban
bleeding disorder
Authors
Magdalena Kaczmarek-Kowalska
Paweł Szczepaniec
References (10)- ROSENTHAL RL, DRESKIN OH, ROSENTHAL N. New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med. 1953; 82(1): 171–174.
- Bolton-Maggs PH. B. Factor XI deficiency and its management. Treatment of hemophilia. World Federation of Hemophilia, Montreal. 2008; 16: 1–14.
- Seligsohn U. Factor XI deficiency. J Thromb Haemost. 2009; 7(supl. 1): 84–87.
- Zawilska K, Chojnowski K, Klukowska A, et al. Polskie zalecenia postępowania w rzadkich niedoborach osoczowych czynników krzepnięcia. Hematologia. 2011; 2: 303–310.
- Bolton-Maggs PH. Factor XI deficiency--resolving the enigma? Hematology Am Soc Hematol Educ Program. 2009: 97–105.
- Myers B, Pavord S, Kean L, et al. Pregnancy outcome in Factor XI deficiency: incidence of miscarriage, antenatal and postnatal haemorrhage in 33 women with Factor XI deficiency. BJOG. 2007; 114(5): 643–646.
- Franchini M, Manzato F, Salvagno GL, et al. The use of desmopressin in congenital factor XI deficiency: a systematic review. Ann Hematol. 2009; 88(10): 931–935.
- O’Connell N. Factor XI deficiency. Seminars in Hematology. 2004; 41: 76–81.
- Berliner S, Horowitz I, Martinowitz U, et al. Dental surgery in patients with severe factor XI deficiency without plasma replacement. Blood Coagul Fibrinolysis. 1992; 3(4): 465–468.
- Younis HS, Crosby J, Huh JI, et al. Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys. Blood. 2012; 119(10): 2401–2408.